Research groups
Danielle Newby
Senior Postdoctoral Researcher in Real World Evidence
I joined NDORMS in April 2022 from the Department of Psychiatry where I led projects related to drug repurposing and understanding risk factors of dementia as well as other mental health and neurological conditions. I have a multidisciplinary background in epidemiology, pharmacology, and machine learning. My complete publication list can be found here.
My main research interests involve triangulating real world evidence from multiple sources such as medical records and genetic data to understand more about what causes certain diseases, how they have changed over time and what we can do to intervene with new or existing interventions and the safety of these interventions.
Specific areas of interest and expertise:
- Descriptive epidemiology for oncology
- Federated network studies for cancer survival
- Signal detection for drug safety
- Drug target Mendelian randomization
Recent publications
-
Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021.
Journal article
Barclay NL. et al, (2024), Sci rep, 14
-
Secular trends in the incidence, prevalence, and survival of primary liver cancer in the United Kingdom from 2000-2021: a population-based cohort study
Preprint
Cuyàs B. et al, (2024)
-
Incidence, prevalence, and survival of colorectal cancer in the United Kingdom from 2000-2021: a population-based cohort study
Preprint
Pedregal-Pascual P. et al, (2024)
-
Incidence, prevalence, and survival of lung cancer in the United Kingdom from 2000-2021: a population-based cohort study.
Journal article
Newby D. et al, (2024), Translational lung cancer research
-
Optimizing the use of electronic medical records for large scale research in psychiatry
Journal article
Newby D. et al, (2024), Translational psychiatry